Kolexia
Baudouin Veronique Pédiatrie
Baudouin Veronique
Pédiatrie
Hôpital Robert-Debré
Paris, France
121 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndrome néphrotique Maladies du rein Lupus érythémateux disséminé Protéinurie Glomérulonéphrite Néphrose Néphrose lipoïdique Défaillance rénale chronique Glomérulonéphrite membranoproliférative

Collaborateurs

Voir plus
Deschenes Georges
Deschenes Georges
Hôpital Robert-Debré, Paris, France
Hogan Julien
Hogan Julien
Hôpital Robert-Debré, Paris, France
Kwon Theresa
Kwon Theresa
Hôpital Robert-Debré, Paris, France
Dossier Claire
Dossier Claire
Hôpital Robert-Debré, Paris, France

Industries

Voir plus
Novartis
1 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
MAJESTY: A Phase III Randomized, Open-Label Active Comparator-Controlled Multicenter Study to Evaluate Efficacy and Safety of Obinutuzumab in Patients With Primary Membranous Nephropathy
Essai Clinique (Roche)   21 mars 2024
POSTERITY: A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescent Patients With Active Class III or IV Lupus Nephritis, Including an Evaluation of Open Label Safety and PK in a Cohort of Pediatric Patients (Aged 5 to < 12)
Essai Clinique (Roche)   15 mars 2024
INShore: A Phase III, International, Multicenter, Randomised Open Label Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Patients With Childhood Onset Idiopathic Nephrotic Syndrome
Essai Clinique (Roche)   27 février 2024
Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score.
Lupus   05 février 2024
OBIRINS: Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Dependant and Frequent Relapsing Nephrotic Syndrome : a Double-blind Multicenter Randomized Controlled Study
Essai Clinique (Assistance publique – Hôpitaux de Paris)   08 novembre 2023
Obinutuzumab in Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome in Children.
Clinical journal of the American Society of Nephrology : CJASN   06 septembre 2023
Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GN.
Clinical journal of the American Society of Nephrology : CJASN   24 août 2023
Obinutuzumab in Primary FSGS: A Single-center, Phase 2 Open-label Trial Evaluating the Efficacy and Safety of OBINUTUZUMAB in Treatment of Immunosuppression-dependent or Immunosuppression/Treatment-resistant Primary FSGS, or Contraindication/Patient Refusal to Take High Dose Corticosteroids
Essai Clinique (Genentech)   13 juin 2023
Optimizing COVID-19 Vaccination Strategy in Pediatric Kidney Transplant Recipients: Humoral and Cellular Response to SARS-CoV-2 mRNA Vaccination.
Transplant international : official journal of the European Society for Organ Transplantation   12 mai 2023
Biallelic loss of function variants are responsible for neonatal systemic hypertension.
Journal of medical genetics   20 avril 2023